D Shyangdan

2.0k total citations
27 papers, 1.5k citations indexed

About

D Shyangdan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, D Shyangdan has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in D Shyangdan's work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (7 papers) and Retinal Diseases and Treatments (6 papers). D Shyangdan is often cited by papers focused on Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (7 papers) and Retinal Diseases and Treatments (6 papers). D Shyangdan collaborates with scholars based in United Kingdom, Canada and Nepal. D Shyangdan's co-authors include Norman Waugh, Christine Clar, Pamela Royle, Rachel Court, Martin Connock, Pawana Sharma, Olalekan A. Uthman, A Snaith, Hema Mistry and Noemi Lois and has published in prestigious journals such as Cochrane Database of Systematic Reviews, BMJ and BMJ Open.

In The Last Decade

D Shyangdan

26 papers receiving 1.5k citations

Peers

D Shyangdan

SURGE

EDM

OPHTH

EPIDE

Qin Wang China

Antonio Gallo France

Steven M. Shaw United Kingdom

Rebeca Reyes‐García Spain

Danuta Rość Poland

Jie Wu China

Soo Young Kim South Korea

Antonio Carletto Italy

Athanasios Aessopos Greece

Qin Wang China

D Shyangdan

474 ×0.9

SURGE

73 ×0.1

EDM

364 ×1.2

322 ×1.3

OPHTH

177 ×0.8

EPIDE

Citations per year, relative to D Shyangdan D Shyangdan (= 1×) peers Qin Wang

Countries citing papers authored by D Shyangdan

Since Specialization

Citations

This map shows the geographic impact of D Shyangdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Shyangdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Shyangdan more than expected).

Fields of papers citing papers by D Shyangdan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Shyangdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Shyangdan. The network helps show where D Shyangdan may publish in the future.

Co-authorship network of co-authors of D Shyangdan

This figure shows the co-authorship network connecting the top 25 collaborators of D Shyangdan. A scholar is included among the top collaborators of D Shyangdan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Shyangdan. D Shyangdan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Freeman, Karoline, Sian Taylor‐Phillips, Martin Connock, et al.. (2017). Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohn’s disease: a systematic review and meta-analysis. BMJ Open. 7(6). e014581–e014581. 11 indexed citations

Mistry, Hema, Martin Connock, Joshua Pink, et al.. (2017). Autologous chondrocyte implantation in the knee: systematic review and economic evaluation. Health Technology Assessment. 21(6). 1–294. 191 indexed citations

Shyangdan, D, Olalekan A. Uthman, & Norman Waugh. (2016). SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. BMJ Open. 6(2). e009417–e009417. 122 indexed citations

Gurung, Tara, Norman Waugh, Joseph Paul O’Hare, & D Shyangdan. (2015). A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide. Diabetes Metabolic Syndrome and Obesity. 8. 363–363. 14 indexed citations

Royle, Pamela, Hema Mistry, Peter Auguste, et al.. (2015). The landmark trials: Diabetic Retinopathy Study and Early Treatment Diabetic Retinopathy Study. 3 indexed citations

Royle, Pamela, Hema Mistry, Peter Auguste, et al.. (2015). Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. Health Technology Assessment. 19(51). 1–248. 73 indexed citations

Ford, John, Christine Clar, Noemi Lois, et al.. (2014). Treatments for macular oedema following central retinal vein occlusion: systematic review. BMJ Open. 4(2). e004120–e004120. 18 indexed citations

Ford, John, D Shyangdan, Olalekan A. Uthman, Noemi Lois, & Norman Waugh. (2014). Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis. BMJ Open. 4(7). e005292–e005292. 22 indexed citations

Ford, John, Noemi Lois, Pamela Royle, et al.. (2013). Current treatments in diabetic macular oedema: systematic review and meta-analysis. BMJ Open. 3(3). e002269–e002269. 92 indexed citations

10.

Shyangdan, D, et al.. (2013). Screening for type 2 diabetes: a short report for the National Screening Committee. Health Technology Assessment. 17(35). 1–90. 92 indexed citations

11.

Sutcliffe, Paul, Martin Connock, Ruth Pulikottil-Jacob, et al.. (2013). Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model. Health Technology Assessment. 17(53). 1–499, v. 27 indexed citations

12.

Waugh, Norman, Eoin P. Cummins, P Royle, et al.. (2013). Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technology Assessment. 17(55). xv–xix, 1. 214 indexed citations

13.

Ford, John, Andrew Elders, D Shyangdan, Pamela Royle, & Norman Waugh. (2012). The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review. BMJ. 345(aug13 1). e5182–e5182. 50 indexed citations

14.

Simkhada, Padam, et al.. (2012). Women’s knowledge of and attitude towards disability in rural Nepal. Disability and Rehabilitation. 35(7). 606–613. 14 indexed citations

15.

Waugh, Norman, et al.. (2012). Exenatide prolonged-release suspension for injection incombination with oral antidiabetic therapy for thetreatment of type 2 diabetes. 1 indexed citations

16.

Shyangdan, D, Christine Clar, Nazim Ghouri, et al.. (2011). Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.. Health Technology Assessment. 15(38). 1–110. 63 indexed citations

17.

Shyangdan, D, Pamela Royle, Christine Clar, et al.. (2011). Glucagon-like peptide analogues for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2013(7). CD006423–CD006423. 205 indexed citations

18.

Shyangdan, D, E Cummins, Pamela Royle, & Norman Waugh. (2011). Liraglutide for the treatment of type 2 diabetes : a single technology appraisal. Warwick Research Archive Portal (University of Warwick). 3 indexed citations

19.

Shyangdan, D, E Cummins, Pamela Royle, & Norman Waugh. (2011). Liraglutide for the treatment of type 2 diabetes. Health Technology Assessment. 15(Suppl 1). 77–86. 11 indexed citations

20.

Shyangdan, D, Pamela Royle, Christine Clar, Pawana Sharma, & Norman Waugh. (2010). Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis. BMC Endocrine Disorders. 10(1). 20–20. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact